Dimension Inx, a biomaterials platform company, announced that they have closed a $12M Series A Round. The round was led by Prime Movers Lab (PML), with participation by returning investors KdT Ventures and Revolution's Rise of the Rest Seed Fund (ROTR). New investors participating in the round include Solas BioVentures, Portal Innovation Ventures, and Alumni Ventures.

Dimension Inx is an emerging leader in biofabrication in medicine. The firm's 3D-Painting Materials Design and Manufacturing System offers the versatility, manufacturability, and affordability necessary for widespread adoption of tissue-engineered regenerative medical products.